Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2016

Open Access 01-12-2016 | Commentary

Transforming healthcare through regenerative medicine

Authors: Zita M. Jessop, Ayesha Al-Sabah, Wendy R. Francis, Iain S. Whitaker

Published in: BMC Medicine | Issue 1/2016

Login to get access

Abstract

Regenerative medicine therapies, underpinned by the core principles of rejuvenation, regeneration and replacement, are shifting the paradigm in healthcare from symptomatic treatment in the 20th century to curative treatment in the 21st century. By addressing the reasons behind the rapid expansion of regenerative medicine research and presenting an overview of current clinical trials, we explore the potential of regenerative medicine to reshape modern healthcare.
Literature
1.
Calne R. The history and development of organ transplantation: biology and rejection. Baillieres Clin Gastroenterol. 1994;8:389–97.CrossRefPubMed
2.
Haseltine W. Regenerative medicine 2003: an overview. J Regener Med. 2003;4:15–8.
3.
Landecker H. Culturing Life. Cambridge, MA: Harvard University Press; 2009.
4.
Stevens LC. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Developmen Biol. 1970;21:364–82.CrossRef
5.
Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154–6.CrossRefPubMed
6.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.CrossRefPubMed
7.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.CrossRefPubMed
8.
Sunderland ME. Studying Development: The Value of Diversity, Theory, and Synthesis. PhD Thesis. Tempe, AZ: Arizona State University; 2008.
9.
O’Dowd A. Peers call for UK to harness “enormous” potential of regenerative medicine. BMJ. 2013;347:f4248.CrossRefPubMed
10.
Mason C, Dunnill P. The strong financial case for regenerative medicine and the regen industry. Regen Med. 2008;3(3):351–63.CrossRefPubMed
11.
Orlando G, Wood KJ, Stratta RJ, Yoo JJ, Atala A, Soker S. Regenerative medicine and organ transplantation: past, present, and future. Transplantation. 2011;91(12):1310–7.CrossRefPubMed
12.
Tsukamoto A, Abbot SE, Kadyk LC, DeWitt ND, Schaffer DV, Wertheim JA, Whittlesey KJ, Werner MJ. Challenging regeneration to transform medicine. Stem Cells Transl Med. 2006;5(1):1–7.CrossRef
13.
14.
15.
16.
17.
18.
Lee MH, Arcidiacono JA, Bilek AM, Wille JJ, Hamill CA, Wonnacott KM, Wells MA, Oh SS. Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States. Tissue Eng Part B Rev. 2010;16(1):41–54.CrossRefPubMed
19.
Ford CE, Hamerton JL, Barnes DW, Loutit JF. Cytological identification of radiation-chimaeras. Nature. 1956;177:452–4.CrossRefPubMed
20.
Cao Y, Vacanti JP, Paige KT, Upton J, Vacanti CA. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg. 1997;100:297–304.CrossRefPubMed
21.
Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, Dodson A, Martorell J, Bellini S, Parnigotto PP, Dickinson SC, Hollander AP, Mantero S, Conconi MT, Birchall MA. Clinical transplantation of a tissue-engineered airway. Lancet. 2008;372:2023–30.CrossRefPubMed
22.
Atala A, Bauer SB, Soker S, Yoo JJ, Retic AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006;367:1241–6.CrossRefPubMed
23.
Gonfiotti A, Jaus MO, Barale D, Baiguera S, Comin C, Lavorini F, Fontana G, Sibila O, Rombolà G, Jungebluth P, Macchiarini P. The first tissue-engineered airway transplantation: 5-year follow-up results. Lancet. 2014;383(9913):238–44.CrossRefPubMed
24.
Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med. 2008;14(2):213–21.CrossRefPubMed
25.
Soto-Gutierrez A, Zhang L, Medberry C, Fukumitsu K, Faulk D, Jiang H. A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods. 2011;17(6):677–86.CrossRefPubMedPubMedCentral
26.
Kemp P. History of regenerative medicine: looking backwards to move forwards. Regen Med. 2006;1(5):653–69.CrossRefPubMed
27.
28.
Vogel G. Regenerative medicine. Report finds misconduct by surgeon. Science. 2015;348(6238):954–5.CrossRefPubMed
29.
Alta CR. On the road (to a cure?) — Stem-cell tourism and lessons for gene editing. N Engl J Med. 2016;374:901–3.CrossRef
30.
Matthews KR, Iltis AS. Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders. BMC Med Ethics. 2015;16:75.CrossRefPubMedPubMedCentral
31.
Bubela T, Li MD, Hafez M, Bieber M, Atkins H. Is belief larger than fact: expectations, optimism and reality for translational stem cell research. BMC Med. 2012;10:133.CrossRefPubMedPubMedCentral
32.
Galbraith DN. Regulatory and microbiological safety issues surrounding cell and tissue-engineering products. Biotechnol Appl Biochem. 2004;40:35–9.CrossRefPubMed
33.
Carpenter MK, Frey-Vasconcells J, Rao MS. Developing safe therapies from human pluripotent stem cells. Nat Biotechnol. 2009;27:606–13.CrossRefPubMed
34.
Chacko BK, Kramer PA, Ravi S, Benavides GA, Mitchell T, Dranka BP, Ferrick D, Singal AK, Ballinger SW, Bailey SM, Hardy RW, Zhang J, Zhi D, Darley-Usmar VM. The Bioenergetic Health Index: a new concept in mitochondrial translational research. Clin Sci (Lond). 2014;127:367–73.CrossRef
35.
Progatzky F, Dallman MJ. Lo Celso. From seeing to believing: labelling strategies for in vivo cell-tracking experiments. Interface. Focus. 2013;3(3):20130001.
36.
Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells. Proc Natl Acad Sci. 2001;98:14541–6.CrossRefPubMedPubMedCentral
37.
Ram-Liebig G, Bednarz J, Stuerzebecher B, Fahlenkamp D, Barbagli G, Romano G, Balsmeyer U, Spiegeler ME, Liebig S, Knispel H. Regulatory challenges for autologous tissue engineered products on their way from bench to bedside in Europe. Adv Drug Deliv Rev. 2015;82-83:181–91.CrossRefPubMed
Metadata
Title
Transforming healthcare through regenerative medicine
Authors
Zita M. Jessop
Ayesha Al-Sabah
Wendy R. Francis
Iain S. Whitaker
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2016
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-016-0669-4

Other articles of this Issue 1/2016

BMC Medicine 1/2016 Go to the issue

Review

Diagnostic ‘omics’ for active tuberculosis

Research article

Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

Research article

Twenty-year trajectories of alcohol consumption during midlife and atherosclerotic thickening in early old age: findings from two British population cohort studies

Opinion

Mirror, mirror on the wall: which microbiomes will help heal them all?

Opinion

Beyond viral suppression of HIV – the new quality of life frontier

Research article

How effective are volunteers at supporting people in their last year of life? A pragmatic randomised wait-list trial in palliative care (ELSA)